Key result
Surgical quality assessment in retroperitoneal liposarcoma particularly benefits young patients with extensive malignant femoral disease.
Why the study?
Does preoperative radiotherapy plus surgery improve the achievement of surgical quality benchmarks compared to surgery alone in patients with primary retroperitoneal liposarcoma?
Does preoperative radiotherapy plus surgery improve the achievement of surgical quality benchmarks compared to surgery alone in patients with primary retroperitoneal liposarcoma?
Aiming to achieve intra- and postoperative benchmarks without performing a comprehensive resection in retroperitoneal liposarcoma is associated with poorer local control, highlighting the need for standardized surgical quality and comprehensive resection.
Answers are grounded in this paper and cite their sources.
Prioritize surgical quality assessment in young retroperitoneal liposarcoma patients; extends RCT evidence for comprehensive resection to optimize local control.
The EORTC-62092 (STRASS) phase III randomized controlled trial evaluated the effect of preoperative radiotherapy on abdominal recurrence free survival in patients with primary retroperitoneal sarcoma. Although surgery represented the control arm, surgical quality in the trial has never been assessed. Recently, benchmark values for comprehensive resection have been introduced to address this gap. We therefore aimed to investigate surgical quality in STRASS using these benchmark criteria.
No takes yet. Share an insight, caveat, or question.
Tirotta et al. (2026) studied this question. Surgical quality assessment in retroperitoneal liposarcoma showed particular benefits for young patients with extensive malignant femoral disease.
Synapse has enriched 10 related papers. Consider them for comparative context: